Shares in Elite Pharmaceuticals Inc. (OTCBB: ELTP) stock did not react well after announcing before the opening bell its patent approval to help prevent Oxycontin abuse from the USPTO. ELTP stock opened the trading session down -11.31% at 0.149 before rallying to the HOD of 0.174, an intra-day gain of 3.57%, before closing down -12.20% at 0.1475. The patent issuance was of ...
23
MAY
MAY
0
Share
